The Specific Management of Anemia and Hypertension in Renal Transplant ( SMAhRT ) recipients study was designed to examine the cardiovascular benefits of RAS blockade with telmisartan @ mg versus placebo , and Hb management with darbepoetin in a randomized , double-blind , single-center controlled trial in @,@ patients over @ years .